Characterization of a Species E Adenovirus Vector as a Zika virus vaccine

The development of a safe and efficacious Zika virus (ZIKV) vaccine remains a global health priority. In our previous work, we developed an Adenovirus vectored ZIKV vaccine using a low-seroprevalent human Adenovirus type 4 (Ad4-prM-E) and compared it to an Ad5 vector (Ad5-prM-E). We found that vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullard, Brianna L., Corder, Brigette N., Gordon, David N., Pierson, Theodore C., Weaver, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046724/
https://www.ncbi.nlm.nih.gov/pubmed/32107394
http://dx.doi.org/10.1038/s41598-020-60238-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046724/
https://www.ncbi.nlm.nih.gov/pubmed/32107394
http://dx.doi.org/10.1038/s41598-020-60238-5

Ejemplares similares